Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.
| Current Price | ₹26,290.80 |
|---|---|
| Market Cap | ₹55,866 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 36 |
| Return on Equity | 34.46% |
| 52-Week Range | ₹25,150.00 – ₹37,000.00 |
| Beta (1Y) | 0.03 |
| Dividend Yield | 2.00% |
1. Pharmaceuticals-100%
Abbott India Ltd. is trading at ₹26,290.80, with a market capitalisation of ₹55,866 Cr.
Abbott India Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Abbott India Ltd. has a P/E of 36 and a return on equity of 34.46%.